Current status of genome-wide scanning for hypertension

Current Opinion in Cardiology

Volumn 22, Issue 4, 2007, Pages 292-297

  Hamet, Pavel ^a   Šeda, Ondřej ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Comparative genomics; Copy number variant; Ecogenetics; Hypertension; Quantitative trait locus

Indexed keywords

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CHROMOSOME 1Q; DIASTOLIC BLOOD PRESSURE; ECOLOGICAL GENETICS; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; GENETIC SCREENING; GENETIC TRAIT; GENETIC VARIABILITY; GENOME; HUMAN; HYPERTENSION; MOLECULAR EVOLUTION; PHARMACOGENETICS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TRANSCRIPTOMICS;

BLOOD PRESSURE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; HYPERTENSION; LINKAGE (GENETICS); QUANTITATIVE TRAIT LOCI;

EID: 34250155660     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328187b502     Document Type: Review

References (44)

1. Seda O, Tremblay J, Sedova L, Hamet P. Integrating genomics and transcriptomics with geo-ethnicity and the environment for the resolution of complex cardiovascular diseases. Curr Opin Mol Ther 2005; 7:583-587.
2. Cowley AW Jr. The genetic dissection of essential hypertension. Nat Rev Genet 2006; 7:829-840. An excellent and comprehensive review of the genetics of hypertension.
3. Hottenga JJ, Whitfield JB, Posthuma D, et al. Genome-wide scan for blood pressure in Australian and Dutch subjects suggests linkage at 5P, 14Q, and 17P. Hypertension 2007; 49:832-838.
4. Kalmyrzaev B, Aldashev A, Khalmatov M, et al. Genome-wide scan for premature hypertension supports linkage to chromosome 2 in a large Kyrgyz family. Hypertension 2006; 48:908-913.
5. Ciullo M, Bellenguez C, Colonna V, et al. New susceptibility locus for hypertension on chromosome 8q by efficient pedigree-breaking in an Italian isolate. Hum Mol Genet 2006; 15:1735-1743. Two creatively utilized methods of pedigree-breaking.
6. Hamet P, Merlo E, Seda O, et al. Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension. Am J Hum Genet 2005; 76:815-832.
7. Chang YP, Liu X, Kim JD, et al. Multiple genes for essential-hypertension susceptibility on chromosome 1q. Am J Hum Genet 2007; 80:253-264. A comprehensive approach to the identification and prioritization of candidate genes in the linkage region.
8. Samani NJ. Genome scans for hypertension and blood pressure regulation. Am J Hypertens 2003; 16:167-171.
9. Twigger SN, Shimoyama M, Bromberg S, et al. The Rat Genome Database, update 2007: easing the path from disease to data and back again. Nucleic Acids Res 2007; 35:D658-D662.
10. Kristjansson K, Manolescu A, Kristinsson A, et al. Linkage of essential hypertension to chromosome 18q. Hypertension 2002; 39:1044-1049.
11. Pankow JS, Rose KM, Oberman A, et al. Possible locus on chromosome 18q influencing postural systolic blood pressure changes. Hypertension 2000; 36:471-476.
12. Fava C, von Wowern F, Berglund G, et al. 24-h ambulatory blood pressure is linked to chromosome 18q21-22 and genetic variation of NEDD4L associates with cross-sectional and longitudinal blood pressure in Swedes. Kidney Int 2006; 70:562-569.
13. Munroe PB, Wallace C, Xue MZ, et al. Increased support for linkage of a novel locus on chromosome 5q13 for essential hypertension in the British Genetics of Hypertension Study. Hypertension 2006; 48:105-111.
14. Hauser ER, Watanabe RM, Duren WL, et al. Ordered subset analysis in genetic linkage mapping of complex traits. Genet Epidemiol 2004; 27:53-63.
15. Pausova Z, Gossard F, Gaudet D, et al. Heritability estimates of obesity measures in siblings with and without hypertension. Hypertension 2001; 38:41-47.
16. Pausova Z, Jomphe M, Houde L, et al. A genealogical study of essential hypertension with and without obesity in French Canadians. Obes Res 2002; 10:463-470.
17. Morris BJ. Dissecting hypertension by obesity identifies a locus at 1p36. Hypertension 2005; 46:1256-1258.
18. Pausova Z, Gaudet D, Gossard F, et al. Genome-wide scan for linkage to obesity-associated hypertension in French Canadians. Hypertension 2005; 46:1280-1285.
19. Wallace C, Xue MZ, Newhouse SJ, et al. Linkage analysis using co-phenotypes in the BRIGHT study reveals novel potential susceptibility loci for hypertension. Am J Hum Genet 2006; 79:323-331. Interesting approach to the integration of endophenotypes into linkage studies of hypertension.
20. Wang T, Elston RC. Regression-based multivariate linkage analysis with an application to blood pressure and body mass index. Ann Hum Genet 2007; 71:96-106.
21. Rice T, Cooper RS, Wu X, et al. Meta-analysis of genome-wide scans for blood pressure in African American and Nigerian samples. The National Heart, Lung, and Blood Institute GeneLink Project. Am J Hypertens 2006; 19:270-274. Important evidence for ethnically specific quantitative trait loci.
22. Kotchen TA, Broeckel U, Grim CE, et al. Identification of hypertension-related QTLs in African American sib pairs. Hypertension 2002; 40:634-639.
23. Ioannidis JP, Ntzani EE, Trikalinos TA. 'Racial' differences in genetic effects for complex diseases. Nat Genet 2004; 36:1312-1318.
24. Charron S, Duong C, Menard A, et al. Epistasis, not numbers, regulates functions of clustered Dahl rat quantitative trait loci applicable to human hypertension. Hypertension 2005; 46:1300-1308.
25. Seda O, Liska F, Krenova D, et al. Dynamic genetic architecture of metabolic syndrome attributes in the rat. Physiol Genomics 2005; 21:243-252.
26. Bell JT, Wallace C, Dobson R, et al. Two-dimensional genome-scan identifies novel epistatic loci for essential hypertension. Hum Mol Genet 2006; 15:1365-1374. First systematic two-dimensional scan of human hypertension.
27. Ueno T, Tremblay J, Kunes J, et al. Gender-specific genetic determinants of blood pressure and organ weight: pharmacogenetic approach. Physiol Res 2003; 52:689-700.
28. Weiss LA, Pan L, Abney M, Ober C. The sex-specific genetic architecture of quantitative traits in humans. Nat Genet 2006; 38:218-222. Seminal paper on the sex-specific genetic architecture of complex traits.
29. Dasgupta K, O'Loughlin J, Chen S, et al. Emergence of sex differences in prevalence of high systolic blood pressure: analysis of a longitudinal adolescent cohort. Circulation 2006; 114:2663-2670.
30. Franceschini N, MacCluer JW, Goring HH, et al. A quantitative trait loci-specific gene-by-sex interaction on systolic blood pressure among American Indians: the Strong Heart Family Study. Hypertension 2006; 48:266-270.
31. Rana BK, Insel PA, Payne SH, et al. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension 2007; 49:96-106.
32. Kunes J, Zicha J. Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view. Clin Sci (Lond) 2006; 111:295-305.
33. Sedova L, Seda O, Kazdova L, et al. Sucrose feeding during pregnancy and lactation elicits distinct metabolic response in offspring of an inbred genetic model of metabolic syndrome. Am J Physiol Endocrinol Metab 2007; 9 January [Epub ahead of print].
34. Buresova M, Zidek V, Musilova A, et al. Genetic relationship between placental and fetal weights and markers of the metabolic syndrome in rat recombinant inbred strains. Physiol Genomics 2006; 26:226-231.
35. Lawlor DA, Hubinette A, Tynelius P, et al. Associations of gestational age and intrauterine growth with systolic blood pressure in a family-based study of 386,485 men in 331,089 families. Circulation 2007; 115:562-568. Raises important considerations of epigenetic factors in the development of hypertension.
36. Yatsu K, Mizuki N, Hirawa N, et al. High-resolution mapping for essential hypertension using microsatellite markers. Hypertension 2007; 49:446-452.
37. Yamada Y, Matsuo H, Segawa T, et al. Assessment of the genetic component of hypertension. Am J Hypertens 2006; 19:1158-1165.
38. Mellen PB, Herrington DM. Pharmacogenomics of blood pressure response to antihypertensive treatment. J Hypertens 2005; 23:1311-1325.
39. Arnett DK, Claas SA, Glasser SP. Pharmacogenetics of antihypertensive treatment. Vascul Pharmacol 2006; 44:107-118.
40. Manunta P, Bianchi G. Pharmacogenomics and pharmacogenetics of hypertension: update and perspectives: the adducin paradigm. J Am Soc Nephrol 2006; 17:S30-S35.
41. Padmanabhan S, Wallace C, Munroe PB, et al. Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension Study. Hypertension 2006; 47:603-608.
42. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006; 444:444-454. Landmark study introducing the complete human genome map of copy number variants.
43. Freeman JL, Perry GH, Feuk L, et al. Copy number variation: new insights in genome diversity. Genome Res 2006; 16:949-961.
44. Stranger BE, Forrest MS, Dunning M, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007; 315:848-853. Crucial study demonstrating nonredundancy of SNPs and copy number variants and their fundamental impact on gene expression.